The nation of Zimbabwe has declined a significant US health deal valued at 367 million US dollars (272 million pounds) over five years because of the United States' demand for confidential biological samples.
This rejection came to light following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official representative later explained that the US was demanding access to health data for scientific study and commercial purposes but was not willing to guarantee the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further talks to find a agreement agreeable to both sides so the country's vital HIV treatment initiative can continue.
Broader Background
This development follows a similar case in neighbouring Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
As per statements, Sixteen African countries have to date signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery with no certainty that the end products would be accessible to our population if a future pandemic emerge."
National Interest and Global Health
He also noted that the American exit from the global health body and its push of one-on-one health agreements were undermining frameworks already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This mechanism is intended to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent co-operation might be structured in a manner that respects the independence and interests of each country."
Medical Community Response
A leading public health body expressed it understood the government's concerns, but suggested that talks need to persist since much of the country's HIV programmes depended on external financing.
"If technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it said.
The halted deal emphasises the complex challenges between receiving vital international aid and protecting a country's data in an increasingly interconnected world.